TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.70
+1.60 (2.16%)
Apr 2, 2025, 1:30 PM CST

TTY Biopharm Company Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
1,4501,1291,094831.89924.18
Upgrade
Depreciation & Amortization
194.26193.1180.69162.79153.86
Upgrade
Other Amortization
8.097.85.594.493.14
Upgrade
Loss (Gain) From Sale of Assets
0.951.933.280.740.32
Upgrade
Asset Writedown & Restructuring Costs
6.8116.180.734.154.58
Upgrade
Loss (Gain) From Sale of Investments
-8.79-0.21-0.16
Upgrade
Loss (Gain) on Equity Investments
-400.05-131.34-116.38-135.18-162.87
Upgrade
Provision & Write-off of Bad Debts
1.36-1.933.5613.58-0.1
Upgrade
Other Operating Activities
202.01122.02110.34110.24-15.66
Upgrade
Change in Accounts Receivable
35.07-116.16-95.4-114.32-36.42
Upgrade
Change in Inventory
-161.27-56.75-83.95155.12-251.8
Upgrade
Change in Accounts Payable
-10.2111.9596.01-23.07-26.35
Upgrade
Change in Unearned Revenue
20.11-18.89-6.6423.48-0.39
Upgrade
Change in Other Net Operating Assets
2.63-179.8943.55222.24-65.98
Upgrade
Operating Cash Flow
1,3491,0851,2361,256526.35
Upgrade
Operating Cash Flow Growth
24.33%-12.17%-1.64%138.69%-56.49%
Upgrade
Capital Expenditures
-125.16-78.35-91.52-60.32-168.11
Upgrade
Sale of Property, Plant & Equipment
3.937.019.390.030.01
Upgrade
Cash Acquisitions
-242.87----
Upgrade
Sale (Purchase) of Intangibles
-9.14-21.23-43.98-13.84-13.75
Upgrade
Investment in Securities
128.18168.5534.68-14.1308.82
Upgrade
Other Investing Activities
1.49-78.62-41.7-80.5620.26
Upgrade
Investing Cash Flow
-243.56-2.63-133.14-168.78147.24
Upgrade
Short-Term Debt Issued
8,05010,28010,8905,4005,400
Upgrade
Long-Term Debt Issued
500400430-720
Upgrade
Total Debt Issued
8,55010,68011,3205,4006,120
Upgrade
Short-Term Debt Repaid
-8,300-10,200-11,231-5,404-5,246
Upgrade
Long-Term Debt Repaid
-409.77-434.17-421.55-16.54-663.65
Upgrade
Total Debt Repaid
-8,710-10,634-11,653-5,421-5,910
Upgrade
Net Debt Issued (Repaid)
-159.7745.83-332.62-20.54210.35
Upgrade
Common Dividends Paid
-870.28-845.41-745.95-994.6-994.6
Upgrade
Other Financing Activities
-21.19-16.75-24.83-28.99-22.36
Upgrade
Financing Cash Flow
-1,051-816.33-1,103-1,044-806.61
Upgrade
Foreign Exchange Rate Adjustments
97.02-2.66135.85-44.91-65.41
Upgrade
Net Cash Flow
151.6263.7135.07-1.48-198.43
Upgrade
Free Cash Flow
1,2241,0071,1441,196358.25
Upgrade
Free Cash Flow Growth
21.57%-12.00%-4.33%233.86%-68.58%
Upgrade
Free Cash Flow Margin
20.77%18.29%22.61%26.37%8.49%
Upgrade
Free Cash Flow Per Share
4.914.044.594.801.44
Upgrade
Cash Interest Paid
38.4634.9923.2218.6719.6
Upgrade
Cash Income Tax Paid
297.06283.71277.92220.22311.47
Upgrade
Levered Free Cash Flow
891.34737.63806.96980.02107.23
Upgrade
Unlevered Free Cash Flow
915.25759.62821.24991.87119.36
Upgrade
Change in Net Working Capital
23.96199.47-2.99-185.84454.14
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.